16
Jun
2020
18:00
BST
Webinar
CCM® Around the World
-
Views:
2216
-
Likes:
2
Overview
This live online webinar is an educational program designed to share the latest updates on a breakthrough device-based therapy for the treatment of moderate to severe heart failure. While cardiac contractility modulation using the Optimizer® device has been well-studied, published and widely available in Europe for a number of years, it was only recently approved in the US. The use of CCM® therapy continues to expand rapidly – which makes now a perfect time to bring the world's most experienced investigators and providers with extensive clinical experience together to discuss the current and future place CCM® may take in the treatment of heart failure.
Faculty:
Thomas M Helms
Karl-Heinz Kuck
William T Abraham
Daniel Burkhoff
Frieder Braunschweig
Jürgen Kuschyk
This webinar is supported by
Agenda
Learning Objectives
- Become aware of the history of Impulse Dynamics and it's founding by a renowned scientist inventor.
- Appreciate the extensive scientific endeavours that resulted in the outcomes that have driven approval by the various regulatory authorities.
- Learn about the mode of action that underpins CCM® therapy.
- Understand the clinical path forward for CCM® therapy.
- Gain an understanding of appropriate patient identification and selection.
- Share patient experiences via case studies presented by the physician with the most extensive clinical experience in the world.
Faculty Biographies
Karl-Heinz Kuck
Prof Karl-Heinz Kuck is the Medical Director at LANS Cardio Hamburg. For many years, he was head of the Department of Cardiology at the Asklepios Klinik St. Georg in Hamburg.
William T Abraham
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.
Frieder Braunschweig
Prof Frieder Braunschweig is the Director of Cardiology at Karolinska University Hospital, Stockholm, SE and a Professor at Karolinska Institutet in Stockholm, SE.